Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
21:10
Peripartum and Pregnancy-Related Considerations in Residency
18:24
CAR T Cells and T-Cell Therapies for Cancer
18:41
ED Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder
26:26
AI and the FDA: Conversation With Robert M. Califf, MD, Commissioner, FDA
14:23
Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a)
16:15
Interim Analyses During Group Sequential Trials With Dr Meurer
54:18
Testosterone & Hypogonadism: A Clinical Perspective w/ Dr. Mohit Khera | Urology Podcast Ep. 124
15:03